Assessing Allopurinol Effect on Metabolic Acidosis in Patients with Chronic renal failure stage 2-4

Not Applicable

• Conditions: Condition 1: CKD. Condition 2: CKD stage 2-4.; Chronic kidney disease; Kidney damage with mild decreased GFR (60-89 mL/min; N18.2-N18.

• Registration Number: IRCT2016122731604N1
• Lead Sponsor: Mashhad University Of Medical Siences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

inclusion:age 18-80,Chronic kidney disease stage 2-4,both gender
exclusion:gout,myeloprolifrative disorder,allopurinol user ,allergy to allopurinol, uric acid>10,active infection

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bicarbonate. Timepoint: before intervention,after 3 month. Method of measurement: blood level meq/L.;Uric acid. Timepoint: before intervention,3 month. Method of measurement: blood level mg/mL.